Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France
NCT02714855
·
clinicaltrials.gov ↗
COMPLETED
Status
2081
Enrollment
INDUSTRY
Sponsor class
Conditions
Anticoagulation
Interventions
DRUG:
Apixaban
Sponsor
Bristol-Myers Squibb